Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

The data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Recent studies suggest that popular weight loss drugs like Ozempic may offer surprising ... evidence linking weight loss to a decreased risk of cancer, this study suggests that the injections ...

So far, researchers have found that these meds may help reduce the risk of cardiovascular disease and colorectal cancer ... GLP-1 receptor agonists (like Ozempic) or a type of medicine known ...

What’s driving the viral trend Measles likely to ‘grumble’ into summer as cases continue to surge Drugs like Ozempic may lower cancer risk if you have diabetes: study The secret to faster ...

Ozempic is a brand name of the drug semaglutide ... But studies published in 2024 showed there was little to no increased risk of contracting thyroid cancer while on these drugs.

Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs have transformed the way we think about our bodies, weight loss, and wellness. Ozempic and other GLP-1 drugs like it ...

An Ozempic Expert Explains What You Need to Know ... finding a difference and others not finding a difference in cancer risk—seemed to come from the fact that some studies do what we did ...

Experts agreed that people on these weight loss drugs are unlikely to have an increased risk for thyroid cancer. A new study found that weight loss drugs like Ozempic and Wegovy may be ...

For years, people taking Ozempic or other drugs in the ... an advisory warning that alcohol raises the risk of at least seven types of cancer, and called for updated health warning labels on ...

Ozempic may also increase the risk for thyroid tumors, according to the drug’s maker. Patients should inform their doctors if they have a family history of thyroid cancer or experience symptoms ...